/PRNewswire/ SOPHiA GENETICS SA (NASDAQ: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,.
Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients
Two nationally known cancer experts detail the similarities between cancer, and other health disparities, experienced by rural and urban populations across the country.